ArticleCardiovascular diabetology. Endocrinology reports2025

Triple arm, prospective, real-world study comparing the efficacy of FDC teneligliptin + dapagliflozin to FDC sitagliptin + dapagliflozin, and FDC linagliptin + empagliflozin in Indian type 2 diabetes mellitus patients using CGM device: the Amplify-TIR study.

Suhas Erande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.